A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/201 (2006.01) A61K 31/22 (2006.01) A61K 31/366 (2006.01) A61K 31/40 (2006.01) A61K 31/405 (2006.01) A61K 31/4418 (2006.01) A61K 31/47 (2006.01) A61K 31/4706 (2006.01) A61K 31/55 (2006.01) A61K 45/00 (2006.01) A61K 45/06 (2006.01) A61P 3/06 (2006.01)
Patent
CA 2560920
The present invention relates to methods of treating atherosclerosis, dyslipidemia, other cardiovascular diseases and related diseases, such as diabetes, using a serine palmitoyltransferase (SPT) inhibitor. The present invention also relates to pharmaceutical compositions and kits that comprise a serine palmitoyltransferase (SPT) inhibitor, optionally with another pharmaceutical agent.
L'invention concerne des méthodes pour traiter l'athérosclérose, la dyslipidémie, et d'autres maladies cardio-vasculaires et maladies associées, notamment les diabètes, à l'aide d'un inhibiteur de sérine palmitoyle transférase (SPT). L'invention concerne également des compositions pharmaceutiques et des trousses comprenant un inhibiteur de sérine palmitoyle transférase (SPT), éventuellement accompagné d'un autre agent pharmaceutique.
Homan Reynold
Karathanasis Sotirios Konstantinou
Panek Robert Lee
Park Tae-Sik
Rekhter Mark David
Smart & Biggar
Warner-Lambert Company Llc
LandOfFree
Use of a serine palmitoyltransferase (spt) inhibitor to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a serine palmitoyltransferase (spt) inhibitor to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a serine palmitoyltransferase (spt) inhibitor to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1804501